[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 56
Citations 0
Letters
July 18, 2012

Medication Discount Program—Reply

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliation:JAMA, Chicago, Illinois (mike.mitka@jamanetwork.org).

JAMA. 2012;308(3):237-238. doi:10.1001/jama.2012.6624

In Reply: The article focused on letters sent by 4 members of Congress requesting information to determine whether the 340B drug pricing program is functioning as intended by law. In their letters, the legislators wrote: “The original intent of the program was to extend the Medicaid drug discount to the most vulnerable patients receiving services at Public Health Service clinics, including individuals who are, ‘medically uninsured, on marginal incomes, and have no other source to turn to for preventive and primary care services.’”1 The quotation regarding those medically uninsured and on marginal incomes was taken from the Senate Committee report that accompanied the 340B statute. While the report conveys the original intent of the program, Drs Hart and Siegel are correct that the statute does not contain that language.

First Page Preview View Large
First page PDF preview
First page PDF preview
×